MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Precipio Total Shareholders Equity 2011-2026 | PRPO
Annual Total Shareholders Equity Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.6 M | 12.1 M | 14.4 M | 16.3 M | 24.6 M | 14.1 M | 13.2 M | 6.12 M | 13 M | -6.46 M | -12.8 M | 6.55 M | 11.4 M | 20.3 M | 11 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.6 M | -12.8 M | 10.6 M |
Quarterly Total Shareholders Equity Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.7 M | 12.3 M | 11.7 M | 12.1 M | 11.9 M | 12.1 M | 12.8 M | 14.4 M | 13 M | 14.1 M | 14.2 M | 16.3 M | 18.3 M | 20.6 M | 22.3 M | 24.6 M | 25.9 M | 27.3 M | 14.5 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 6.12 M | 6.12 M | 6.12 M | 6.12 M | 13 M | 13 M | 13 M | 13 M | -6.46 M | -6.46 M | -6.46 M | -19.4 M | -2.1 M | -12.8 M | -12.8 M | -12.8 M | 6.55 M | 6.55 M | 6.55 M | 6.55 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 20.3 M | 20.3 M | 20.3 M | 20.3 M | 11 M | 11 M | 11 M | 11 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27.3 M | -19.4 M | 10.4 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 16.65 | - | $ 179 M |  China |
|
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
456 M | $ 23.91 | -3.18 % | $ 664 M |  USA |
 |
Agilent Technologies
A
|
5.39 B | $ 111.9 | -2.59 % | $ 34 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.07 | -2.89 % | $ 1.97 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 1.58 | -3.31 % | $ 2.1 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
11.9 B | $ 25.43 | -6.23 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
203 M | $ 5.16 | -6.18 % | $ 306 M | USA |
 |
CareDx, Inc
CDNA
|
303 M | $ 20.0 | -8.74 % | $ 1.07 B | USA |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 14.83 | -3.07 % | $ 448 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 122.47 | -3.51 % | $ 19.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
-2.22 M | $ 0.6 | -2.01 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 165.5 | -0.77 % | $ 8.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 57.41 | -2.95 % | $ 3.43 B | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 81.21 | -2.26 % | $ 10.2 B | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 81.06 | -2.98 % | $ 5.47 B | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.96 | 1.5 % | $ 8.67 M | USA |
 |
Senseonics Holdings
SENS
|
61 M | $ 6.79 | -5.43 % | $ 283 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Medpace Holdings
MEDP
|
459 M | $ 412.32 | 0.62 % | $ 11.9 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.16 | -1.02 % | $ 4.96 M | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 115.57 | 12.76 % | $ 9.53 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 253.92 | -2.18 % | $ 21.1 B | USA |
 |
NeoGenomics
NEO
|
837 M | $ 8.48 | -5.99 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
101 M | $ 119.58 | -0.41 % | $ 5.59 B | USA |
 |
National Research Corporation
NRC
|
14 M | $ 15.61 | -7.3 % | $ 349 M | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.63 | -4.34 % | $ 429 M | USA |
 |
Natera
NTRA
|
706 M | $ 193.42 | -3.37 % | $ 19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 188.44 | -3.39 % | $ 20.9 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
7.38 M | - | -16.95 % | $ 1.54 M | USA |
 |
Organovo Holdings
ONVO
|
10.5 M | - | -2.3 % | $ 19.4 M | USA |